Log in to save to my catalogue

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b58355a680de466ca6f90e400f43d8a5

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

About this item

Full title

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Psychopharmacology, 2020, Vol.10, p.2045125320935306-2045125320935306

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

As yet, no agents have been approved for the treatment of COVID-19, although several experimental drugs are being used off licence. These may have serious adverse effects and potential drug interactions with psychotropic agents. We reviewed the common agents being used across the world for the treatment of COVID-19 and investigated their drug inter...

Alternative Titles

Full title

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b58355a680de466ca6f90e400f43d8a5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b58355a680de466ca6f90e400f43d8a5

Other Identifiers

ISSN

2045-1253

E-ISSN

2045-1261

DOI

10.1177/2045125320935306

How to access this item